Royalty Pharma plcRPRXNASDAQ
LOADING
|||
Revenue Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
5.29%
↑ 247% above average
Average (26q)
1.52%
Historical baseline
Range
High:20.90%
Low:-21.31%
Volatility
2768.5%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 5.29% |
| Q2 2025 | 1.83% |
| Q1 2025 | -4.28% |
| Q4 2024 | 5.13% |
| Q3 2024 | 5.10% |
| Q2 2024 | -5.41% |
| Q1 2024 | -4.71% |
| Q4 2023 | 11.14% |
| Q3 2023 | -0.35% |
| Q2 2023 | -21.31% |
| Q1 2023 | 20.90% |
| Q4 2022 | -1.35% |
| Q3 2022 | 7.00% |
| Q2 2022 | -4.64% |
| Q1 2022 | -2.37% |
| Q4 2021 | -1.72% |
| Q3 2021 | 5.55% |
| Q2 2021 | -3.15% |
| Q1 2021 | 0.15% |
| Q4 2020 | 6.27% |
| Q3 2020 | 5.38% |
| Q2 2020 | 2.01% |
| Q1 2020 | 9.49% |
| Q4 2019 | -1.46% |
| Q3 2019 | 1.46% |
| Q2 2019 | 5.23% |
| Q1 2019 | 0.00% |